Introduction: Synthetic implantable, biodegradable polymers offer the susta
ined focal release of disparate therapeutic agents for the treatment of hum
an malignant brain rumors. The role of polymeric devices for the local deli
very of radiosensitizers remains unexplored however We therefore quantified
the release of the representative radiosensitizers IUdR (5-iodo-2'-deoxyur
idine), tirapazamine (3-amino-1,2,4-benzotriazine-1, 4-dioxide) and etanida
zole [N-(2-hydroxyethyl)-2-nitro-1-imidazole-1-acetamide] from the [(poly(b
is(p-carboxyphenoxyl-propane) (PCPP):sebacic acid (SA) (PCPP:SA ratio 20:80
)] polymer.
Methods: For measurements of controlled release, triplicate polymer discs w
ere incubated for known intervals in 2 mi 0.1 phosphate-buffered saline, pH
7.4, 37 degrees C. Using a predefined schedule, the supernatant fractions
were systematically removed and replaced with fresh solution. The supernata
nt fractions were measured The cumulative percentage of the loaded drug tha
t appeared in these serial supernatant fractions was plotted vs. time. The
percentage of the drug that was loaded into each polymer and that was relea
sed vs. time was fit to the power function of the form y = (a) *t(b), where
y is the cumulative released agent, a and b are constants and t is time (d
ays).
Results: The IUdR was released over an interval of approximately one week,
while the release of the tirapazimine persisted for over 100 days. The etan
idazole was released most rapidly, over a period of hours. Modeling of rele
ase showed that regardless of percentage loading of the drug the monoexpone
ntial function showed high correlation of the fit of the plot of the releas
e vs, time. Conclusions: These results suggest that the hydrophilicity and
percentage loading of the drug predominantly determine the rate of release.
Based upon these results, IUdR and tirapazamine warrant preclinical testin
g for radiosensitization of human malignant brain rumors via the synthetic
implantabte, biodegradable polymeric devices.